| pubmed-article:1515369 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1515369 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
| pubmed-article:1515369 | lifeskim:mentions | umls-concept:C0221920 | lld:lifeskim |
| pubmed-article:1515369 | lifeskim:mentions | umls-concept:C0031671 | lld:lifeskim |
| pubmed-article:1515369 | lifeskim:mentions | umls-concept:C0205183 | lld:lifeskim |
| pubmed-article:1515369 | lifeskim:mentions | umls-concept:C1704711 | lld:lifeskim |
| pubmed-article:1515369 | lifeskim:mentions | umls-concept:C0205349 | lld:lifeskim |
| pubmed-article:1515369 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:1515369 | pubmed:dateCreated | 1992-10-2 | lld:pubmed |
| pubmed-article:1515369 | pubmed:abstractText | Phospholipase C-gamma 1 (PLC-gamma 1) is a well characterized substrate for the epidermal growth factor receptor tyrosine kinase and has been implicated in the intracellular biochemical signaling cascade which occurs following stimulation of cells with epidermal growth factor. The in vivo localization of PLC-gamma 1 was examined by immunohistochemistry in sections of normal human skin and in skin sections from a diverse series of hyperproliferative epidermal conditions (psoriasis, seborrheic keratoses, acrochordons, and margins near second-degree burns). Immunoreactive PLC-gamma 1 was detected only in the basal compartment of normal skin but was readily detectable in both the basal and outer epidermal compartment in hyperproliferative skin conditions. In addition, immunoreactive PLC-gamma 1 colocalizes with immunoreactive epidermal growth factor receptor in both normal and hyperproliferative epidermis. | lld:pubmed |
| pubmed-article:1515369 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1515369 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1515369 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1515369 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1515369 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1515369 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1515369 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1515369 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1515369 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1515369 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1515369 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1515369 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:1515369 | pubmed:issn | 1044-9523 | lld:pubmed |
| pubmed-article:1515369 | pubmed:author | pubmed-author:KingL ELEJr | lld:pubmed |
| pubmed-article:1515369 | pubmed:author | pubmed-author:CarpenterGG | lld:pubmed |
| pubmed-article:1515369 | pubmed:author | pubmed-author:GatesR ERE | lld:pubmed |
| pubmed-article:1515369 | pubmed:author | pubmed-author:NanneyL BLB | lld:pubmed |
| pubmed-article:1515369 | pubmed:author | pubmed-author:TodderudGG | lld:pubmed |
| pubmed-article:1515369 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1515369 | pubmed:volume | 3 | lld:pubmed |
| pubmed-article:1515369 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1515369 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1515369 | pubmed:pagination | 233-9 | lld:pubmed |
| pubmed-article:1515369 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:1515369 | pubmed:meshHeading | pubmed-meshheading:1515369-... | lld:pubmed |
| pubmed-article:1515369 | pubmed:meshHeading | pubmed-meshheading:1515369-... | lld:pubmed |
| pubmed-article:1515369 | pubmed:meshHeading | pubmed-meshheading:1515369-... | lld:pubmed |
| pubmed-article:1515369 | pubmed:meshHeading | pubmed-meshheading:1515369-... | lld:pubmed |
| pubmed-article:1515369 | pubmed:meshHeading | pubmed-meshheading:1515369-... | lld:pubmed |
| pubmed-article:1515369 | pubmed:meshHeading | pubmed-meshheading:1515369-... | lld:pubmed |
| pubmed-article:1515369 | pubmed:meshHeading | pubmed-meshheading:1515369-... | lld:pubmed |
| pubmed-article:1515369 | pubmed:meshHeading | pubmed-meshheading:1515369-... | lld:pubmed |
| pubmed-article:1515369 | pubmed:meshHeading | pubmed-meshheading:1515369-... | lld:pubmed |
| pubmed-article:1515369 | pubmed:meshHeading | pubmed-meshheading:1515369-... | lld:pubmed |
| pubmed-article:1515369 | pubmed:meshHeading | pubmed-meshheading:1515369-... | lld:pubmed |
| pubmed-article:1515369 | pubmed:meshHeading | pubmed-meshheading:1515369-... | lld:pubmed |
| pubmed-article:1515369 | pubmed:meshHeading | pubmed-meshheading:1515369-... | lld:pubmed |
| pubmed-article:1515369 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1515369 | pubmed:articleTitle | Altered distribution of phospholipase C-gamma 1 in benign hyperproliferative epidermal diseases. | lld:pubmed |
| pubmed-article:1515369 | pubmed:affiliation | Department of Plastic Surgery and Cell Biology, Vanderbilt University, Nashville, Tennessee 37232. | lld:pubmed |
| pubmed-article:1515369 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1515369 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:1515369 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1515369 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1515369 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1515369 | lld:pubmed |
